|Bid||92.50 x 200|
|Ask||0.00 x 0|
|Day's Range||104.05 - 105.50|
|52 Week Range||90.10 - 112.97|
|PE Ratio (TTM)||18.97|
|Earnings Date||Apr 18, 2018 - Apr 23, 2018|
|Forward Dividend & Yield||2.00 (1.92%)|
|1y Target Est||109.31|
Quest Diagnostics Inc (NYSE: DGX ) shares have derated over the last year, as the stock trades only slightly above its closest peer Laboratory Corp. of America Holdings (NYSE: LH ), according to Morgan ...
Quest Diagnostics' (DGX) upgraded long-term guidance based on its new and extended two-point strategy looks promising. However, it expresses resentment against the recent PAMA-related CMS proposal.
Quest Diagnostics Inc (NYSE: DGX ) has a number of bullish catalysts on the horizon , enough for one Wall Street analyst to upgrade the stock. The Analyst Argus analyst Jasper Hellweg upgraded Quest from ...
This could indicate that investors who seek to profit from falling equity prices are not currently targeting DGX. Over the last one-month, outflows of investor capital in ETFs holding DGX totaled $6.87 billion.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting DGX. Over the last one-month, outflows of investor capital in ETFs holding DGX totaled $10.02 billion.
Secaucus, NJ and New Brunswick, NJ, Feb. 26, 2018-- Quest Diagnostics, the world’ s leading provider of diagnostic information services, and Rutgers University– New Brunswick have collaborated to open ...
SECAUCUS, N.J., Feb. 22, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Raymond James 39th Annual Institutional Investors Conference in Orlando. Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.
Stock Monitor: Agilent Technologies Post Earnings Reporting LONDON, UK / ACCESSWIRE / February 22, 2018 / Active-Investors.com has just released a free earnings report on Quest Diagnostics Inc. (NYSE: ...
The Zacks Analyst Blog Highlights: CA, Quest Diagnostics, Pfizer, United Parcel and U.S. Bancorp
The healthcare sector has a higher prevalence of companies with sustainable competitive advantages compared to other sectors which implies it may continue generating robust excess returns. When the economy isRead More...
Quest Diagnostics (DGX) grows on infectious disease testing, prescription drug monitoring and wellness business. New collaborations with hospitals and integrated delivery networks are other positives.
Rise in bond yields increased the opportunity cost of investing in other asset classes such as equities, thus, making them less attractive.
Secaucus, NJ, Feb. 01, 2018-- Quest Diagnostics, the world's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of Mobile Medical ...
Quest Diagnostics' (DGX) year-over-year revenue improvement in Q4 came on the back of successful execution of its two-point strategy of accelerating growth and driving operational excellence.